Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acalabrutinib in Combination With R-CHOP in Previously Untreated Mantle Cell Lymphoma
NCT04566887Phase 2Active, not recruiting
- Sponsor
- University Health Network
- Start
- Mar 2021
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acalabrutinib tablet (Variant 1) in mantle cell lymphoma (MCL), sponsored by University Health Network. Started Mar 2021; status: active, not recruiting.
02
Drugs
acalabrutinib tablet (Variant 1)
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT04566887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04566887.